How does insurance-company M&A get IRDAI approval (and the 100% FDI change)?

Executive Summary

Acquiring control of an Indian insurance company demands a multi-stage regulatory approval from the Insurance Regulatory and Development Authority of India (IRDAI). The 2024 policy shift allowing 100% foreign direct investment (FDI) in insurance has opened the sector to global insurers, multinational financial institutions, and private equity funds, but approval timelines, lock-in obligations, and compliance requirements remain stringent.

Key takeaways:

• IRDAI insurance M&A approval is mandatory for any change in shareholding that results in acquisition of control, regardless of stake size
• The 100% FDI policy permits full foreign ownership but does not eliminate prior approval requirements, fit-and-proper assessments, or post-acquisition restrictions
• Approval timelines typically span six to twelve months, depending on transaction complexity, documentation completeness, and regulatory queries
• Foreign acquirers face post-acquisition lock-in obligations (typically five years) restricting exit or share transfer without IRDAI consent
• Transfer of insurance business through merger, demerger, or portfolio transfer requires separate approval under Section 35 of the Insurance Act, 1938, and confirmation from the National Company Law Tribunal (NCLT)
• Failure to obtain IRDAI approval before completing acquisition constitutes a regulatory violation and may result in penalties, suspension, or cancellation of registration
• Ongoing compliance obligations cover solvency margins, investment norms, actuarial reporting, board composition, and policyholder protection

Why Insurance M&A Requires IRDAI Approval

Insurance businesses are not ordinary corporate entities. They hold policyholder funds, manage actuarial liabilities spanning decades, and operate on regulatory capital adequacy frameworks. Transfer of control over these critical financial services entities requires prior regulatory consent to protect policyholder interests, maintain financial stability, and ensure acquirers meet fit-and-proper criteria.

Under the Insurance Act, 1938, and the Insurance Regulatory and Development Authority Act, 1999 (IRDAI Act), any change in ownership or control of an insurance company requires IRDAI approval before completion. This applies to:

• Acquisition of shares or voting rights resulting in direct or indirect control
• Transfer of shareholding exceeding prescribed thresholds
• Change in promoters, promoter groups, or controlling shareholders
• Merger, amalgamation, or demerger of insurance companies
• Scheme of arrangement involving transfer of insurance business
• Acquisition of insurance business through slump sale, asset transfer, or portfolio acquisition

Unlike general corporate acquisitions where share transfers can be completed by private agreement and filing with the Registrar of Companies, insurance M&A is subject to prior regulatory consent. The regulatory framework exists to prevent regulatory arbitrage, offshore structuring, or opaque ownership structures while enforcing corporate governance, solvency, and capital adequacy requirements.

The 100% FDI Policy Change: What Actually Changed

In 2021, the Government of India amended the Insurance Act, 1938, allowing foreign investment in Indian insurance companies to increase from 49% to 74%. In 2024, further amendments and policy clarifications removed the requirement for prior government approval, permitting foreign investors to hold up to 100% equity in Indian insurance companies, subject to IRDAI approval and prescribed conditions.

This represented a significant policy shift. Previously, foreign investors could only acquire minority stakes or co-invest alongside Indian promoters. Now, foreign insurers, multinational financial institutions, and private equity funds can acquire full ownership of Indian insurance companies.

However, the 100% FDI policy change did not eliminate:

• The requirement for IRDAI insurance M&A approval
• Fit-and-proper criteria for acquirers
• Lock-in obligations for foreign investors
• Regulatory conditions on governance, solvency, and operational compliance
• Sectoral caps on specific classes of insurance business (if applicable)
• Restrictions on transfer or exit within prescribed periods
• Ongoing compliance obligations under IRDAI regulations

In practical terms, foreign investors can now own 100% of Indian insurance companies, but they must obtain IRDAI approval for the acquisition and comply with post-acquisition lock-in, governance, solvency, and operational obligations.

What Constitutes Acquisition of Control Under IRDAI Regulations

IRDAI approval is triggered not by share purchase alone, but by acquisition of control. Control is defined under IRDAI (Registration of Indian Insurance Companies) Regulations, 2022, and IRDAI (Transfer of Equity Shares of Indian Insurance Companies) Regulations, 2015, as:

• The right to appoint or remove the majority of the board of directors
• The right to control the composition of the board of directors
• Holding shares or voting rights exceeding prescribed thresholds
• The ability to direct or influence the management or policy decisions of the insurance company
• Direct or indirect shareholding that results in effective management control

Control can arise through:

• Direct shareholding
• Indirect shareholding through holding companies, subsidiaries, or associate entities
• Acting in concert with other shareholders under shareholder agreements or voting arrangements
• Exercising management rights, board nomination rights, or veto rights under corporate agreements

Even if a foreign investor acquires less than 100% equity, if the acquisition results in control (as defined above), IRDAI approval is mandatory. Failure to obtain approval before completing the acquisition constitutes a regulatory violation.

The IRDAI Approval Process: Step by Step

Step 1: Pre-Transaction Due Diligence and Fit-and-Proper Assessment

The acquirer must ensure compliance with IRDAI's fit-and-proper criteria. IRDAI evaluates:

• Financial soundness and solvency of the acquirer
• Track record in insurance or financial services
• Governance structure and integrity of promoters
• Compliance history in other jurisdictions
• Source of funds and financing structure
• Absence of adverse regulatory actions, criminal proceedings, or financial misconduct

If the acquirer fails the fit-and-proper test, IRDAI may reject the application.

Step 2: Application for IRDAI Approval

The acquirer (or the target insurance company on behalf of the acquirer) must file an application with IRDAI for approval of the proposed acquisition. The application must include:

• Details of the proposed transaction structure
• Shareholding pattern before and after the acquisition
• Details of the acquirer, including financial statements, business history, and regulatory compliance record
• Source of funds and financing arrangements
• Draft shareholder agreements, subscription agreements, or share purchase agreements
• Proposed board composition and key management personnel
• Business plan and operational strategy post-acquisition
• Compliance with solvency margin, capital adequacy, and regulatory capital requirements
• Details of any indirect shareholding or acting-in-concert arrangements

IRDAI may request additional documentation, clarifications, or modifications to the transaction structure.

Step 3: Regulatory Review and Approval

IRDAI reviews the application to assess:

• Compliance with fit-and-proper criteria
• Impact on policyholder interests
• Financial stability and solvency of the insurance company post-acquisition
• Compliance with FDI policy and sectoral caps (if applicable)
• Governance structure and operational control mechanisms
• Absence of regulatory arbitrage or opaque ownership structures

The approval process typically takes six to twelve months. If IRDAI raises objections, the acquirer must address concerns through clarifications, modifications, or restructuring of the transaction.

Step 4: Issuance of IRDAI Approval Order

If satisfied, IRDAI issues an approval order authorizing the acquisition. The approval order may include conditions such as:

• Lock-in period for equity investment
• Restrictions on transfer or exit
• Compliance obligations regarding solvency, capital adequacy, and governance
• Reporting obligations for post-acquisition changes in management, board composition, or operational strategy
• Restrictions on dividend distribution or capital repatriation
• Ongoing compliance with IRDAI regulations

Step 5: Post-Acquisition Compliance and Reporting

After completing the acquisition, the acquirer must:

• File updated shareholding details with IRDAI
• Report changes in board composition, key management personnel, or governance structure
• Comply with ongoing solvency margin and capital adequacy requirements
• Submit periodic financial statements, actuarial reports, and compliance certificates
• Obtain IRDAI approval for any subsequent transfer of shares or change in control

Failure to comply with post-acquisition obligations may result in regulatory action, including penalties, suspension, or cancellation of the insurance company's registration.

Post-Acquisition Lock-In Obligations for Foreign Investors

One of the most significant regulatory changes introduced after the 100% FDI policy shift is the post-acquisition lock-in obligation. Under IRDAI regulations, foreign investors acquiring control of Indian insurance companies are subject to a lock-in period during which they cannot exit the investment or transfer their shareholding without prior IRDAI approval.

The lock-in period is typically:

• Five years for foreign investors acquiring majority control
• Longer if the acquisition involves distressed insurers, restructuring, or government-supported transactions

The lock-in obligation applies to:

• Direct shareholding by the foreign investor
• Indirect shareholding through holding companies or subsidiaries
• Transfer of shares to related entities or affiliates

Exceptions to the lock-in may be granted if:

• The transfer is to another fit-and-proper entity approved by IRDAI
• The transfer is required due to regulatory obligations in other jurisdictions
• The transfer is part of a corporate restructuring approved by IRDAI

The lock-in obligation is designed to prevent speculative acquisitions, ensure long-term commitment to the Indian insurance market, protect policyholder interests by ensuring continuity of operations, and discourage regulatory arbitrage or quick-exit strategies.

For foreign investors, the lock-in obligation affects:

• Exit strategy and investment return timelines
• Transaction structuring and financing arrangements
• Valuation and deal pricing
• Shareholder agreements and governance rights

Transfer of Insurance Business Under Section 35 of the Insurance Act, 1938

IRDAI approval for acquisition of shares is distinct from approval for transfer of insurance business. Under Section 35 of the Insurance Act, 1938, any scheme involving transfer of insurance business (including amalgamation, demerger, or portfolio transfer) requires prior approval from IRDAI and confirmation from the National Company Law Tribunal (NCLT).

This applies to:

• Merger of two insurance companies
• Demerger of insurance business
• Transfer of policyholder portfolio from one insurer to another
• Acquisition of insurance business through slump sale or asset transfer

The approval process under Section 35 requires:

1. Filing of a scheme of arrangement with IRDAI
2. Approval from IRDAI based on actuarial soundness, policyholder protection, and financial viability
3. Filing of the scheme with NCLT for judicial approval
4. Convening of meetings of policyholders, creditors, and shareholders (if required by NCLT)
5. Final approval from NCLT

The Section 35 approval process is separate from, and additional to, the IRDAI approval for acquisition of shares. Foreign investors acquiring Indian insurance companies must determine whether the transaction involves acquisition of shares (requiring IRDAI approval only) or transfer of insurance business (requiring both IRDAI and NCLT approval under Section 35).

Regulatory Differences Between Life Insurers, General Insurers, and Reinsurers

IRDAI approval requirements vary depending on the type of insurance business:

Life Insurers

• Subject to stricter actuarial compliance and long-term liability management
• Approval process focuses on policyholder protection, actuarial soundness, and solvency margins
• Lock-in obligations may be longer due to long-term nature of life insurance policies

General Insurers

• Subject to investment norms, reinsurance compliance, and claims management obligations
• Approval process focuses on capital adequacy, underwriting discipline, and regulatory compliance

Reinsurers

• Subject to global reinsurance standards, capital adequacy, and cross-border regulatory coordination
• Approval process focuses on financial strength, global compliance, and systemic risk

Foreign investors must understand the regulatory framework specific to the type of insurance business being acquired.

Common Transaction Risks and Execution Failures

Risk 1: Underestimating IRDAI Approval Timelines

Many foreign investors assume IRDAI approval is a formality. In practice, the approval process can take six to twelve months, depending on the complexity of the transaction, completeness of documentation, and regulatory queries. Transaction financing structures, deal closing deadlines, and operational transition plans must account for realistic approval timelines.

Risk 2: Failure to Comply with Fit-and-Proper Criteria

Acquirers with adverse regulatory history, financial instability, or governance concerns may fail IRDAI's fit-and-proper assessment, resulting in rejection of the application. Thorough pre-transaction due diligence on the acquirer's compliance record, financial soundness, and source of funds is critical.

Risk 3: Ignoring Post-Acquisition Lock-In Obligations

Foreign investors structuring acquisitions for short-term exit strategies may violate lock-in obligations, resulting in regulatory penalties and exit restrictions. Investment return expectations, financing structures, and shareholder agreements must accommodate the five-year lock-in period.

Risk 4: Inadequate Due Diligence on Regulatory Compliance

Failure to conduct thorough due diligence on the target insurer's solvency, actuarial compliance, and regulatory obligations can result in post-acquisition liabilities and operational disruptions. Buyers must verify compliance with solvency margins, investment norms, policyholder protection requirements, and actuarial reporting obligations.

Risk 5: Failure to Obtain Section 35 Approval for Business Transfer

Transactions involving transfer of insurance business (not just shares) require separate Section 35 approval. Failure to obtain this approval renders the transaction void. Acquirers must distinguish between share acquisition and business transfer and initiate the appropriate approval process.

Risk 6: Incomplete Documentation or Inaccurate Disclosures

Incomplete or inaccurate documentation can cause delays or rejections. Applications must include comprehensive financial statements, business plans, source of funds documentation, and compliance certifications. Any material misrepresentation or omission may result in rejection or withdrawal of approval.

Strategic Guidance for Foreign Investors

1. Conduct Regulatory Due Diligence Early

Engage with IRDAI early in the transaction process to understand approval timelines, documentation requirements, and potential objections. Early regulatory consultation can identify deal-breakers and allow for transaction restructuring before significant transaction costs are incurred.

2. Structure Transactions to Comply with Lock-In Obligations

Design exit strategies, financing structures, and shareholder agreements that comply with lock-in requirements. Investment return expectations and transaction pricing must reflect the five-year minimum holding period and restrictions on share transfer.

3. Ensure Compliance with Fit-and-Proper Criteria

Foreign investors should prepare comprehensive documentation demonstrating financial soundness, governance integrity, and regulatory compliance. Any adverse regulatory actions, financial misconduct, or governance deficiencies in other jurisdictions may disqualify the acquirer.

4. Coordinate IRDAI Approval with Other Regulatory Consents

Insurance M&A may require approvals from Competition Commission of India (CCI), Reserve Bank of India (RBI) for foreign exchange compliance, and Registrar of Companies for share transfer filings. Coordinate approval timelines to avoid deal delays and ensure simultaneous fulfillment of all regulatory conditions.

5. Plan for Post-Acquisition Governance and Reporting Obligations

Establish compliance systems for ongoing IRDAI reporting, solvency monitoring, and actuarial compliance. Post-acquisition integration plans must accommodate regulatory reporting obligations, board composition requirements, and key management personnel approvals.

6. Maintain Open Communication with IRDAI

Foster dialogue with IRDAI throughout the approval process to allow for real-time feedback on potential issues. Proactive engagement can expedite the approval process and reduce the risk of objections or rejection.

Frequently Asked Questions

What is IRDAI approval, and why is it required for insurance M&A in India?

IRDAI approval is mandatory regulatory consent required before acquiring control of an Indian insurance company. It ensures that acquirers meet fit-and-proper criteria, policyholder interests are protected, and the transaction complies with solvency, governance, and regulatory capital requirements under the Insurance Act, 1938, and IRDAI regulations.

Does the 100% FDI policy eliminate the need for IRDAI approval?

No. The 100% FDI policy allows foreign investors to hold full ownership of Indian insurance companies, but it does not eliminate the requirement for prior IRDAI approval. Foreign investors must obtain regulatory consent, comply with fit-and-proper criteria, and adhere to post-acquisition lock-in obligations.

What is the typical timeline for obtaining IRDAI approval for insurance M&A?

The approval process typically takes six to twelve months, depending on transaction complexity, completeness of documentation, and regulatory queries. Acquirers should factor in realistic approval timelines when structuring transaction financing, deal closing deadlines, and operational transition plans.

What is the lock-in period for foreign investors acquiring control of Indian insurance companies?

The lock-in period is typically five years for foreign investors acquiring majority control. During this period, foreign investors cannot exit the investment or transfer their shareholding without prior IRDAI approval. The lock-in may be longer for distressed insurers, restructuring, or government-supported transactions.

What documents are required when applying for IRDAI approval?

Key documents include the application form, audited financial statements for at least three prior years, details of the acquirer (including business history and regulatory compliance record), source of funds and financing arrangements, draft shareholder agreements, proposed board composition and key management personnel, business plan and operational strategy post-acquisition, compliance with solvency margin and capital adequacy requirements, and details of indirect shareholding or acting-in-concert arrangements.

What is the difference between IRDAI approval for share acquisition and Section 35 approval for business transfer?

IRDAI approval for share acquisition permits the transfer of shareholding and change in control. Section 35 approval under the Insurance Act, 1938, is required for transfer of insurance business through merger, demerger, or portfolio transfer. Section 35 approval requires both IRDAI consent and confirmation from the National Company Law Tribunal (NCLT). Transactions involving transfer of insurance business require both approvals.

What are common compliance challenges when seeking IRDAI approval?

Common challenges include meeting fit-and-proper criteria, demonstrating financial soundness and solvency, complying with post-acquisition lock-in obligations, providing comprehensive and accurate documentation, addressing regulatory queries on governance structure and operational control, and coordinating IRDAI approval with other regulatory consents (CCI, RBI, ROC).

How can companies mitigate legal risks in insurance M&A transactions?

To mitigate legal risks, companies should engage local legal advisors early in the transaction process, conduct thorough regulatory due diligence on the target insurer's compliance record, structure transactions to comply with lock-in obligations, ensure comprehensive and accurate documentation, maintain open communication with IRDAI, coordinate approval timelines with other regulatory consents, and establish post-acquisition compliance systems for ongoing reporting and solvency monitoring.

What happens if the IRDAI application is rejected?

If rejected, companies can address the grounds for rejection and resubmit the application with clarifications, modifications, or restructuring of the transaction. If IRDAI rejection is based on fit-and-proper concerns, regulatory history, or financial instability, the acquirer may need to substitute a different buyer or abandon the transaction.

Why is it essential to have local legal support in insurance M&A?

Local legal support provides insight into specific regulatory frameworks, compliance issues, and IRDAI approval processes. Local advisors can navigate regulatory complexities, draft comprehensive applications, engage with IRDAI on behalf of the acquirer, coordinate approval timelines with other regulatory consents, and establish post-acquisition compliance systems.

About LawCrust

LawCrust Global Consulting Ltd. is the enterprise legal and consulting arm of the LawCrust Group, delivering lawyer-led corporate legal services, alternative legal services (ALSP), legal process outsourcing (LPO), legal operations support, and AI-enabled legal infrastructure for global businesses, multinational corporations, law firms, procurement-led enterprises, general counsels, investors, and institutional clients.

With operational headquarters in Mumbai's Bandra Kurla Complex (BKC) and a strategic US presence through LawCrust Inc., Delaware, we support cross-border legal and commercial operations involving India, the United States, the Middle East, and other international jurisdictions.

Since 2016, LawCrust has successfully handled over 10,000 legal matters through a strong network of 70+ in-house lawyers and senior partnered advocates.

For expert legal assistance:

Call Now: +91 8097842911

Email: inquiry@lawcrust.com